Neuberger Berman Group’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-81,727
| Closed | -$3.09M | – | 2103 |
|
|
2025
Q1 | $3.09M | Sell |
81,727
-3,405
| -4% | -$129K | ﹤0.01% | 1026 |
|
|
2024
Q4 | $6.97M | Buy |
85,132
+2,399
| +3% | +$196K | 0.01% | 880 |
|
|
2024
Q3 | $9.45M | Sell |
82,733
-25,359
| -23% | -$2.9M | 0.01% | 809 |
|
|
2024
Q2 | $8.16M | Buy |
108,092
+5,781
| +6% | +$437K | 0.01% | 803 |
|
|
2024
Q1 | $6.99M | Buy |
102,311
+16,144
| +19% | +$1.1M | 0.01% | 860 |
|
|
2023
Q4 | $5.41M | Buy |
86,167
+19,976
| +30% | +$1.25M | ﹤0.01% | 892 |
|
|
2023
Q3 | $3.37M | Buy |
66,191
+1,308
| +2% | +$66.7K | ﹤0.01% | 972 |
|
|
2023
Q2 | $3.24M | Buy |
64,883
+34,658
| +115% | +$1.73M | ﹤0.01% | 984 |
|
|
2023
Q1 | $1.13M | Buy |
30,225
+2,539
| +9% | +$95.2K | ﹤0.01% | 1216 |
|
|
2022
Q4 | $1.33M | Buy |
+27,686
| New | +$1.33M | ﹤0.01% | 1161 |
|